ArticleMolecular therapy. Nucleic acids2024

DNA/RNA heteroduplex technology with cationic oligopeptide reduces class-related adverse effects of nucleic acid drugs.

Masahiro Ohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.